Published in AIDS Weekly, July 21st, 2003
Highly active antiretroviral therapy was introduced around 1996 and immediately brought about a substantial reduction in illness and death for people with HIV-1 infection. Amanda Mocroft from the Royal Free and University College Medical School, London, and colleagues investigated whether the short-term benefits of HAART have been sustained by prospectively analyzing around 9800 patients with HIV/AIDS across 70 centers in Europe, Israel, and Argentina.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.